FDA orphan drug designation for zenocutuzumab and racemetyrosine: A milestone achievement in drug development for advanced pancreatic cancer
Biogen has entered into a binding agreement with Denali Therapeutics to jointly develop and commercialise therapeutics for Parkinson’s disease.
MePIS OPEX is a cutting-edge software solution that forms the basis for improvements in productivity in the life science production.
Solid tumour personalised immunotherapy company Imvax has raised $112m in a Series C funding round. How can Imvax’s multi-specific antigen approach improve survival for glioblastoma patients?
The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been contracted to conduct a clinical study of Atossa Therapeutics’ proprietary drug candidate AT-301, to be administered by nasal spray. Avance has successfully completed multiple clinical studies of Atossa’s proprietary Endoxifen.
In June, Peter Huber Kältemaschinenbau AG from Offenburg was presented with the "Economic Magnet" seal, awarded to organisations who exhibit strong performance in seven indicative areas.
Usually, people who are not a part of the translation industry are not familiar with the differences between translation and interpreting and would need some clarification by a professional before deciding what they do need in terms of linguistic services.
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.